Xponance, Inc. Maravai Lifesciences Holdings, Inc. Transaction History

Xponance, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$5.11 - $8.76 $3,607 - $6,184	-706 Reduced 6.42%	10,297 $89,000
Q4 2023 Jan 31, 2024	BUY	$4.7 - $9.87 $1,837 - $3,859	391 Added 3.68%	11,003 $72,000
Q3 2023 Oct 23, 2023	BUY	$9.14 - $12.85 $804 - $1,130	88 Added 0.84%	10,612 $106,000
Q2 2023 Jul 13, 2023	SELL	$12.09 - $15.0 $60,558 - $75,135	-5,009 Reduced 32.25%	10,524 $130,000
Q1 2023 Apr 17, 2023	BUY	$12.99 - $16.48 $13,899 - $17,633	1,070 Added 7.4%	15,533 $217,000
Q4 2022 Jan 23, 2023	BUY	$12.5 - $24.78 $17,937 - $35,559	1,435 Added 11.01%	14,463 $0
Q3 2022 Oct 24, 2022	BUY	$20.6 - $30.37 $3,914 - $5,770	190 Added 1.48%	13,028 $333,000
Q2 2022 Aug 02, 2022	BUY	$26.05 - $37.48 $16,698 - $24,024	641 Added 5.26%	12,838 $365,000
Q1 2022 Apr 20, 2022	SELL	$24.46 - $40.92 $13,208 - $22,096	-540 Reduced 4.24%	12,197 $430,000
Q4 2021 Jan 31, 2022	BUY	$35.0 - $45.94 $42,245 - $55,449	1,207 Added 10.47%	12,737 $534,000
Q3 2021 Nov 05, 2021	BUY	$36.8 - $60.62 $107,529 - $177,131	2,922 Added 33.95%	11,530 $566,000
Q2 2021 Aug 12, 2021	BUY	$32.46 - $45.0 $279,415 - $387,360	8,608 New	8,608 $359,000

234

140M

223K

19.4K

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $723M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

Stay updated on Xponance, Inc. with notifications on news.